SPOTLIGHT -
Michael Angarone, DO: Monkeypox Infection, Public Awareness, and High-Risk Patients
Dr. Angarone highlighted several key takeaways from his presentation at Pri-Med Midwest.
Introducing The Qazi Corner: A Gastroenterology Newsletter Featuring Taha Qazi, MD
The Qazi Corner will be a quarterly newsletter led by Taha Qazi, MD, of the Cleveland Clinic and featuring new data, conference highlights, and perspectives of leading gastroenterologists.
Michael Angarone, DO: Emerging Infectious Diseases, Vector-Borne Viruses
A discussion regarding highlights from Dr. Michael Angarone’s presentation on emerging infectious diseases.
Heart Team: Making Ground on Women's Cardiovascular Health
Martha Gulati, MD, joins episode 2 to discuss the burden of gender disparity in cardiovascular research, screening and care.
Karan Lal, DO: Eczema Awareness Month and FDA Approval of Dupilumab
A discussion with Dr. Lal on the successful trials and recent approval of dupilumab as a treatment for skin inflammation.
Robert Cionni, MD: Innovations in Drug Delivery for Glaucoma Treatment
The SpyGlass IOL platform showcased a 45% drop in mean intraocular pressure at 3 months in first-in-human glaucoma trial.
David Lally, MD: Insights into Safety Data on EYP-1901 for nAMD
Safety data of the bioerodible sustained delivery intravitreal anti-VEGF treatment indicate no ocular or systemic serious adverse events with mild adverse events.
David Boyer, MD: Significance of 24-Month Safety Data on Pegcetacoplan in GA
A discussion into safety data from the Phase 3 DERBY and OAKS trials on pegcetacoplan with Dr. Boyer at AAO 2022.
Caroline Baumal, MD: The Promising Durability of Faricimab for DME
Two-year results from YOSEMITE and RHINE suggest that the positive results of faricimab for DME in year one carried into second year. Dr. Caroline Baumal joins for an in-depth discussion on the findings.
Jennifer Lim, MD: Extended Durability in nAMD, DME Achieved with Faricimab
Faricimab treatment for both DME and nAMD was able to reliably get to 16 week dosing in 60% of eyes from YOSEMITE and RHINE and TENAYA and LUCERNE.
Steven Yeh, MD: Artificial Intelligence Improves Diabetic Retinopathy Detection
Dr. Yeh discusses how Innovations in AI may improve access for patients in resource limited setting and improve detection of vision-threatening diseases.
Dilsher Dhoot, MD: Analysis of OTX-TKI Implant Shows Promise for Wet AMD Treatment
The data show 80% of patients were rescue-free up to 6 months with a single OTX-TKI implant injection.
Rishi Singh, MD: Efficacy of Pegcetacoplan for GA Based on 24-Month Data
A significant rate of reduction of geographic atrophy growth with pegcetacoplan was observed in both DERBY and OAKS over a 24-month period.
Charles Wykoff, MD: Shifting the Treatment Paradigm with Pegcetacoplan for GA
A look into major takeaways on efficacy, safety and functional data from the DERBY and OAKS trials on pegcetacoplan.
Peter J Kertes, MD: Insights into the TALON Trial on Brolucizumab Versus Aflibercept
Brolucizumab was deemed superior to aflibercept in treatment naive patients with neovascular age-related macular degeneration.
Efanesoctocog Alfa: The Breakthrough Hemophilia Therapy Candidate
Dr. Steven Pipe talks about the profound effect the novel recombinant factor VIII candidate demonstrated in patients with hemophilia A.
Steven Pipe, MD: Novel Hemophilia A Therapy Offers Unprecedented Bleed Protection
"We've never had any prophylactic therapy that maintains patients at this level of hemostatic protection well into the normal range for the majority of the week," Dr. Steven Pipe says.
Amit Thosani, MD: The Modern Field of Cardiac Arrhythmia Treatment
Dr. Thosani discusses the convergence of technology and physiology, treatment advancements, and virtual medicine capabilities in the field of heart arrhythmia.
James Palmer, MD, FARS: Chronic Rhinosinusitis And Phase 3 Trials For Treatment Device
A discussion on the recent success of phase 3 trials regarding chronic sinusitis and nasal polyp treatment.
Sara Mednick, PhD: Why is Sleep so Beneficial?
Dr. Sara Mednick's pursuit to understand how to improve intelligence led her to an extensive career of studying the various mechanisms of sleep.
Sara Mednick, PhD: Sleep is the Best Way to Get Smart
Dr. Mednick's latest book, The Power of the Downstate, focuses on the integrated role of sleep by following the "rhythm of upstates and downstates" that people operate in every day.
Dr. Reid Robison, MD: Treatment-Resistant Depression and Psychedelic Medicine Acceptance
Dr. Reid Robison, MD, MBA, described his research on clinical depression and the recent acceptance of psychedelic medicine.
Discussion On Older Homeless Mortality Rates, Future Research
Rebecca T. Brown, MD, MPH, describes contributing factors to older homeless adult mortality and future topics of interest in this field.
Heart Team: The Evolving Role of Kidney Disease in CVD
In the first episode of our monthly series, cardiologists Jorge Plutzky, MD, and Michael Farkouh, MD, interview nephrologist Matthew Weir, MD.
Addressing Older Homeless Adult Health Concerns
Rebecca T. Brown, MD, MPH, discusses the growing prevalence of older homeless adults, and what diseases community leaders and caregivers are combating most frequently in them.
Sanjai Rao, MD: Long-Acting Injectables for Schizophrenia
Treatment adherence remains a concern in psychiatry.
Anne Marie Van Hoven, MD: Patient-Centered Care in Diabetes
A conversation on advancements in diabetes, the rising cost of insulin, and advice regarding disease management.
Anita Clayton, MD: Women's Issues in Psychiatry
Postpartum depression rates have increased since the COVID-19 pandemic.
Michael Thase, MD: Risk Factors for Chronically Depressed Patients
Alcohol, stress, drug use, and not seeking help are all risk factors for chronic depression.
John J. Miller, MD: Guidance on Cannabis Use in Psychiatry
CBD has shown promise in treating anxiety and psychosis.
